Geographic origin, type and classification of lesions of clinically suspected and laboratory confirmed BUD patients.

Table 1 shows the geographic origin of all suspected and confirmed BUD patients, and type/category of lesions of confirmed BUD patients who presented from September 2010 through April 2012 in Togo. More than 85% of confirmed BUD patients originated from the districts Yoto and Zio of region “Maritime”.
aPatients were confirmed by dry-reagent-based IS2404, standard gel-based IS2404 PCR and/or IS2404 quantitative real-time PCR. BUD, Buruli ulcer disease.
bNumber of confirmed BUD patients per district.
cCategory I, single lesion <50 mm in diameter.
dCategory II, single lesion between 50 and 150 mm in diameter.
eCategory III, single lesion >150 mm in diameter or multiple lesions, osteomyelitis or lesions at critical sites.
fLaboratory confirmed BUD patients were referred to CHR, Tsévié, for antimycobacterial treatment.